Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 2
2015 3
2016 2
2017 3
2018 1
2019 3
2020 5
2021 8
2022 9
2023 11
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

41 results

Results by year

Filters applied: . Clear all
Page 1
Real-world effectiveness and safety of oral semaglutide in people living with type 2 diabetes: A nationwide multicentre retrospective observational study (ENDO2 S-RWD).
Moreno-Pérez O, Reyes-Garcia R, Modrego-Pardo I, Doulatram-Gamgaram VK, Cases CC, Guillen-Morote C, Mendoza NA, Tejera-Pérez C, Cárdenas-Salas J, Martínez-Fuster S, Lardiés-Sánchez B, Márquez-Pardo R, Pinés P, Fernández-García JC; SEEN Diabetes Area. Moreno-Pérez O, et al. Among authors: tejera perez c. Diabetes Obes Metab. 2024 Apr;26(4):1519-1523. doi: 10.1111/dom.15431. Epub 2023 Dec 27. Diabetes Obes Metab. 2024. PMID: 38151966 No abstract available.
Real-world safety and effectiveness of dapagliflozin in people living with type 1 diabetes in Spain: The Dapa-ON multicenter retrospective study.
Durán-Martínez M, Azriel S, Doulatram-Gamgaram VK, Moreno-Pérez Ó, Pinés-Corrales PJ, Tejera-Pérez C, Merino-Torres JF, Brito-Sanfiel M, Chico A, Marco A, García-Fernández E, Martínez-Montoro JI; Diabetes Area of the Spanish Society of Endocrinology and Nutrition (SEEN). Durán-Martínez M, et al. Among authors: tejera perez c. Diabetes Metab. 2024 Jan;50(1):101501. doi: 10.1016/j.diabet.2023.101501. Epub 2023 Dec 5. Diabetes Metab. 2024. PMID: 38061425 Free article.
Survey on Endocrinology and Nutrition undergraduate teaching in Spain-2021.
Pinés-Corrales PJ, Hanzu FA, Casañ Fernández R, Fernández Martínez A, Tejera Pérez C, Escalada San Martín FJ, Bretón Lesmes I; Members of the Governing Boards of the Spanish Society of Endocrinology and Nutrition (SEEN) SEEN Foundation (FSEEN) and SEEN Management Advisory Board. Pinés-Corrales PJ, et al. Among authors: tejera perez c. Endocrinol Diabetes Nutr (Engl Ed). 2023 Sep;70 Suppl 3:36-49. doi: 10.1016/j.endien.2023.08.006. Epub 2023 Aug 19. Endocrinol Diabetes Nutr (Engl Ed). 2023. PMID: 37604746
[Review of real-life teduglutide experience].
Campos Martín C, Tejera Pérez C, Virgili-Casas N, Irles-Rocamora JA. Campos Martín C, et al. Among authors: tejera perez c. Nutr Hosp. 2023 Aug 28;40(4):886-894. doi: 10.20960/nh.04646. Nutr Hosp. 2023. PMID: 37409717 Free article. Review. Spanish.
Glycaemic and insulinaemic impact of a diabetes-specific oral nutritional supplement with extra-virgin olive oil in patients with type 2 diabetes mellitus at nutritional risk: a randomized, double-blind, crossover, multicentre clinical trial (DIACARE).
García Almeida JM, Vegas Aguilar IM, Calleja Fernández A, Porca Fernández C, Casañas Quintana T, Tejera Pérez C, Tinahones Madueño FJ, Bellido Guerrero D. García Almeida JM, et al. Among authors: tejera perez c. Nutr Hosp. 2023 Aug 28;40(4):692-700. doi: 10.20960/nh.04577. Nutr Hosp. 2023. PMID: 37409714 Free article. Clinical Trial. English.
[Organoleptic evaluation of a diabetes-specific oral nutritional supplement with extra virgin olive oil in patients at nutritional risk and type 2 diabetes mellitus: Double-blind, randomized, crossover and multicenter clinical trial (DIACARE)].
Vegas Aguilar IM, Porca Fernández C, Casañas Quintana T, Calleja Fernández A, Tejera Pérez C, Tinahones Madueño FJ, Bellido Guerrero D, García Almeida JM. Vegas Aguilar IM, et al. Among authors: tejera perez c. Nutr Hosp. 2023 Aug 28;40(4):686-691. doi: 10.20960/nh.04569. Nutr Hosp. 2023. PMID: 37409710 Free article. Clinical Trial. Spanish.
Comprehensive approach to people with type 2 diabetes. Diabetes Knowledge Area of the Spanish Society of Endocrinology and Nutrition.
Reyes-García R, Moreno-Pérez Ó, Bellido V, Botana-López M, Duran Rodríguez-Hervada A, Fernández-García D, Fernández-García JC, Gargallo-Fernández M, González-Clemente JM, Jódar-Gimeno E, López de la Torre Casares M, López-Fernández J, Marco Martínez A, Mezquita-Raya P, Rozas-Moreno P, Tejera-Pérez C, Escalada-San Martín J; members of the Diabetes Area of the SEEN. Reyes-García R, et al. Among authors: tejera perez c. Endocrinol Diabetes Nutr (Engl Ed). 2023 Mar;70 Suppl 1:95-102. doi: 10.1016/j.endien.2023.03.002. Epub 2023 Mar 9. Endocrinol Diabetes Nutr (Engl Ed). 2023. PMID: 36906509
GALIPDIA study: Reaching lipid targets in a population with type 2 diabetes (T2DM) from the Northwest of Spain.
Villar-Taibo R, Fernández-Rodríguez E, Tejera-Pérez C, Díaz-Ortega C, Sánchez-Sobrino P, Palmeiro-Carballeira R, Rodríguez-Novo N, Rodríguez-Carnero G, Pinal-Osorio I, Cotovad-Bellas L, Díaz-Trastoy O, Mantiñán-Gil B, Álvarez-Castro P, Andújar Plata P, Seoane-Cruz I, Prieto-Tenreiro A, Argüeso Armesto R, Fernández-Pombo A, Sánchez-Bao A, Vidal-Casariego A. Villar-Taibo R, et al. Among authors: tejera perez c. Endocrinol Diabetes Nutr (Engl Ed). 2023 Jan;70(1):29-38. doi: 10.1016/j.endien.2022.06.017. Endocrinol Diabetes Nutr (Engl Ed). 2023. PMID: 36764745
41 results